« Back to list Conference call to review topline data from the SERENITY At-Home Pivotal Phase 3 trial evaluating the safety of BXCL501 Aug 27, 2025 at 8:00 AM EDT Listen to webcast Supporting Materials SERENITY At-Home Pivotal Phase 3 Safety Trial Topline Results Presentation 3.5 MB
